Colon and rectum cancer screening coverage in Europe by country
Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.
Countries reporting
20
Highest
73.5%
Finland
Lowest
7.5%
Serbia
Median
41.6%
Years covered
18
2008β2025
Data points
209
What the numbers show
Colon and rectum cancer screening coverage in Europe is currently reported for 20 countries. The highest value is 73.5% in Finland; the lowest is 7.5% in Serbia.
The median across all reporting countries is 41.6%, and the mean is 41.4%.
The gap between the highest and lowest reporting country is a factor of about 10.
Over the past decade 13 countries rose and 7 fell. The largest increase was in Serbia (up 177.8%), and the largest decrease in Germany (down 24.2%).
Colon and rectum cancer screening coverage in Europe: full country ranking
| # | Country | Latest | Year | 10-year change | Trend |
|---|---|---|---|---|---|
| 1 | Finland | 73.5% | 2024 | down 7.5% | falling |
| 2 | Netherlands | 67.1% | 2024 | down 6.4% | falling |
| 3 | Estonia | 61.5% | 2024 | up 47.5% | rising |
| 4 | Slovenia | 60.6% | 2025 | up 10.0% | rising |
| 5 | Denmark | 59.5% | 2023 | down 6.7% | falling |
| 6 | Lithuania | 57.9% | 2024 | up 38.1% | rising |
| 7 | Belgium | 51.9% | 2024 | up 64.5% | rising |
| 8 | Malta | 49.4% | 2024 | down 16.6% | falling |
| 9 | Moldova | 44.6% | 2024 | up 16.1% | rising |
| 10 | Ireland | 43.9% | 2024 | up 9.2% | rising |
| 11 | Turkey | 39.2% | 2025 | up 86.5% | rising |
| 12 | Italy | 35.8% | 2024 | down 16.9% | falling |
| 13 | Croatia | 34.0% | 2025 | up 70.0% | rising |
| 14 | Czechia | 31.1% | 2024 | up 1.0% | rising |
| 15 | France | 29.6% | 2024 | up 15.2% | rising |
| 16 | Latvia | 28.0% | 2025 | up 156.9% | rising |
| 17 | Montenegro | 22.7% | 2024 | down 4.2% | volatile |
| 18 | Portugal | 16.1% | 2024 | up 76.9% | rising |
| 19 | Germany | 15.0% | 2019 | down 24.2% | falling |
| 20 | Serbia | 7.5% | 2024 | up 177.8% | rising |
About this data
Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.